Drug Maker Krka with Half-Year Profit of EUR 24.6m
Novo Mesto, 29 August - Pharmaceuticals Krka reported sales revenues of SIT 46.2bn (EUR 196.6m) in the first half-year, up by nine percent from the same period last year. The net profit grew by 24 percent to stand at SIT 5.8bn (EUR 24.6m), the Novo mesto-based company said on Friday.
The rest of this news item is available to subscribers.
The news item consists of 1.515 characters (without spaces) or 293 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.